|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 271/02 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07C 271/02 | (2013.01) | ||
| A61K 31/325 | (2006.01) | ||
| C07D 209/08 | (2013.01) | ||
| C07D 215/18 | (2013.01) | ||
| A61K 31/405 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 217/04 | (2013.01) | ||
| C07D 209/42 | (2006.01) | ||
| C07D 231/56 | (2013.01) | ||
| C07D 235/16 | (2006.01) | ||
| C07D 235/16 | (2013.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 487/04 | (2013.01) | ||
| C07D 209/42 | (2013.01) | ||
| A61K 31/405 | (2013.01) | ||
| A61K 31/416 | (2013.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/403 | (2013.01) | ||
| A61K 31/404 | (2013.01) |
| (11) | Number of the document | 3286164 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16783866.3 |
| Date of filing the European patent application | 2016-04-21 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/028674 |
| Date | 2016-04-21 |
| (87) | Number | WO 2016/172358 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 201562150763 P | 2015-04-21 | US | |
| 201562220057 P | 2015-09-17 | US | |
| 201562220187 P | 2015-09-17 | US | |
| 201562219859 P | 2015-09-17 | US | |
| 201562241532 P | 2015-10-14 | US |
| (72) |
NARAYANAN, Ramesh , US
MILLER, Duane D. , US
PONNUSAMY, Thamarai , US
HWANG, Dong-Jin , US
HE, Yali , US
PAGADALA, Jayaprakash , US
DUKE, Charles B. , US
COSS, Christopher C. , US
DALTON, James T. , US
|
| (73) |
Oncternal Therapeutics, Inc. ,
12230 El Camino Real
Suite 230, San Diego CA 92130,
US
University of Tennessee Research Foundation , 211 Conference Center Building 600 Henley Street, Knoxville, TN 37996, US |
| (54) | SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF |
| SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF |